Juvenile ankylosing spondylitis
ICD-10 M08.1 is a billable code used to indicate a diagnosis of juvenile ankylosing spondylitis.
Juvenile ankylosing spondylitis (JAS) is a chronic inflammatory disease primarily affecting the axial skeleton, characterized by inflammation of the sacroiliac joints and spine. It typically presents in adolescents and young adults, often leading to progressive stiffness and pain in the lower back and hips. Anatomically, the condition involves the sacroiliac joints, lumbar spine, and can extend to the thoracic spine and cervical spine. Pathophysiologically, JAS is associated with the HLA-B27 antigen and is characterized by enthesitis, where inflammation occurs at the sites where tendons and ligaments attach to bone. Clinically, patients may experience reduced spinal mobility, postural changes, and systemic symptoms such as fatigue. Early diagnosis and management are crucial to prevent long-term disability and improve quality of life.
Orthopedic documentation should include imaging studies (X-rays, MRI) showing sacroiliitis, functional assessments (e.g., range of motion), and treatment plans including physical therapy.
Common scenarios include surgical interventions for severe spinal deformities or joint replacements in advanced cases.
Joint-specific considerations include monitoring for hip involvement and assessing spinal mobility.
Rheumatologic documentation must include inflammatory markers (ESR, CRP), disease activity scores (BASDAI), and patient-reported outcomes.
Autoimmune scenarios may involve managing comorbidities such as uveitis or psoriasis.
Systemic involvement should be documented, particularly in cases of extra-articular manifestations.
Functional assessments should include mobility evaluations and rehabilitation goals tailored to the patient's needs.
Rehabilitation scenarios may involve physical therapy for pain management and improving range of motion.
Mobility limitations and the need for assistive devices should be clearly documented.
Used for follow-up visits to manage JAS and assess treatment efficacy.
Documentation must include history, examination findings, and treatment plan.
Rheumatology and orthopedics may require additional details on joint involvement and functional status.
Key symptoms include chronic lower back pain, stiffness, particularly in the morning, reduced spinal mobility, and potential involvement of peripheral joints. Patients may also experience systemic symptoms such as fatigue and inflammation.
